These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37934254)

  • 1. Prognostic nutritional index and serum lactate dehydrogenase predict the prognosis of nasopharyngeal carcinoma patients who received intensity-modulated radiation therapy.
    Zhang C; Zhan Z; Fang Y; Ruan Y; Lin M; Dai Z; Zhang Y; Yang S; Xiao S; Chen B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17795-17805. PubMed ID: 37934254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of pretreatment prognostic nutritional index and lactated dehydrogenase in locally advanced nasopharyngeal carcinoma patients.
    Xiong Y; Shi LL; Zhu LS; Peng G
    Ann Palliat Med; 2021 Apr; 10(4):4122-4133. PubMed ID: 33832314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.
    Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy.
    Topkan E; Yucel Ekici N; Ozdemir Y; Besen AA; Mertsoylu H; Sezer A; Selek U
    Ear Nose Throat J; 2021 Feb; 100(2):NP69-NP76. PubMed ID: 31184210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.
    Chen Z; Guo Q; Lu T; Lin S; Zong J; Zhan S; Xu L; Pan J
    Med Sci Monit; 2017 Jan; 23():437-445. PubMed ID: 28120819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.
    Zhou GQ; Tang LL; Mao YP; Chen L; Li WF; Sun Y; Liu LZ; Li L; Lin AH; Ma J
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e359-65. PubMed ID: 22000748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis.
    Yang L; Xia L; Wang Y; Hong S; Chen H; Liang S; Peng P; Chen Y
    PLoS One; 2016; 11(7):e0158853. PubMed ID: 27399281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients.
    Tu X; Ren J; Zhao Y
    Oral Oncol; 2020 Nov; 110():104991. PubMed ID: 32919361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma.
    Küçükarda A; Erdoğan B; Gökyer A; Sayın S; Gökmen İ; Özcan E; Hacıoğlu MB; Uzunoğlu S; Çiçin İ
    Support Care Cancer; 2022 Mar; 30(3):2131-2139. PubMed ID: 34677649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Pretreatment Prognostic Nutritional Index (PNI) in Patients with Nasopharyngeal Carcinoma: A Meta-Analysis.
    Gao QL; Shi JG; Huang YD
    Nutr Cancer; 2021; 73(9):1657-1667. PubMed ID: 32924631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic role of prognostic nutritional index in nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Tang M; Jia Z; Zhang J
    Int J Clin Oncol; 2021 Jan; 26(1):66-77. PubMed ID: 33029749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prognostic nutritional index is associated with poor outcome in middle-aged and elderly patients with non-metastatic nasopharyngeal carcinoma: a retrospective cohort study.
    Wu B; Ni LQ; Wang Y; Yang HH; Zhao SK
    Support Care Cancer; 2022 Nov; 30(11):8895-8904. PubMed ID: 35879471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Zhou GQ; Ren XY; Mao YP; Chen L; Sun Y; Liu LZ; Li L; Lin AH; Mai HQ; Ma J
    Sci Rep; 2016 Mar; 6():22326. PubMed ID: 26928265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
    Liao JF; Ma L; Du XJ; Lan M; Guo Y; Zheng L; Xia YF; Luo W
    PLoS One; 2016; 11(1):e0146787. PubMed ID: 26824230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Zeng YY; Xiang ZZ; He T; Liu F; Shao BF; Yan RN; Ma JC; Wang XR; Liu L
    Oral Oncol; 2020 Dec; 111():104924. PubMed ID: 32736209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.
    Hung TM; Chen CC; Lin CY; Ng SH; Kang CJ; Huang SF; Liao CT; Fan KH; Wang HM; Chang JT
    Oral Oncol; 2014 Mar; 50(3):228-33. PubMed ID: 24394562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
    Zhang MX; Li J; Shen GP; Zou X; Xu JJ; Jiang R; You R; Hua YJ; Sun Y; Ma J; Hong MH; Chen MY
    Eur J Cancer; 2015 Nov; 51(17):2587-95. PubMed ID: 26318726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.
    Tang LQ; Hu DP; Chen QY; Zhang L; Lai XP; He Y; Xu YX; Wen SH; Peng YT; Chen WH; Guo SS; Liu LT; Qian CN; Guo X; Zeng MS; Mai HQ
    PLoS One; 2015; 10(4):e0122965. PubMed ID: 25874450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
    Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
    Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Feng M; Wang W; Fan Z; Fu B; Li J; Zhang S; Lang J
    Radiat Oncol; 2013 Sep; 8():208. PubMed ID: 24007375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.